“Sanofi’s proprietary Apidra brand insulin has increased in price by 1,123% since 1996. So they’ve turned to the black market, trading the insulin that Corely’s insurer will buy with other diabetic people they meet on the internet, who are covered on plans that buy the kind of insulin Corely needs to not slip into a coma and die before her tenth birthday.”
Read more: http://boingboing.net/2017/04/27/cvs-caremark.html